期刊文献+

影响儿童肝母细胞瘤预后的多因素分析 被引量:2

Multivariate prognostic analysis of hepatoblastoma in children.
原文传递
导出
摘要 目的探讨影响肝母细胞瘤患儿预后的因素。方法收集2002年1月至2011年6月青岛大学医学院附属医院小儿血液科42例肝母细胞瘤患儿临床资料,其中未手术组8例,手术组34例,对其实验室检查、病理分型、治疗前病变范围(PRETEXT)分期及预后情况进行回顾性分析及随访。Kaplan-Meier法计算5年生存率并绘制生存曲线,Log-rank检验进行各因素亚组间生存率比较;Cox多因素回归对差异有统计学意义的因素进行多因素分析。结果 42例中存活29例,5年生存率为64.4%,其中手术组34例中死亡5例,5年生存率81.4%。血C反应蛋白(CRP)、甲胎蛋白(AFP)、乳酸脱氢酶(LDH)、病理分型及PRETEXT分期的不同亚组患儿生存率间的比较,差异均有统计学意义(P<0.05),其中CRP升高、LDH升高、AFP>10000μg/L、胚胎型、PRETEXTIV期及转移组的生存率明显降低(P<0.05);手术组Cox多因素分析示病理分型、分期及AFP水平对患儿生存率的影响差异均有统计学意义(P<0.05)。结论病理分型、PRETEXT分期及血清AFP水平为影响肝母细胞瘤患儿预后的独立因素。熟悉肝母细胞瘤临床和实验室检查特点并尽早明确诊断及分期,积极手术及规范化疗有利于改善患儿预后。 To explore the prognostic factors of hepatoblastoma (HB) patients in children. Methods For- ty-two patients diagnosed with hepatoblastoma between Jan.2002 and Jun.2011 in our department were divided into two groups : 8 in the unoperated group and 34 in the operated group.The results of their laboratory examinations, pathology, staging and prognosis were reviewed and analyzed by SPSS 17.0.Kaplan-Meier method was used to evaluate survival rates and to draw the survival curve ; Log-rank test was used for univariate analysis and Cox regression was used for multivariate analysis. Results The 5-year survival rate in the total 42 cases and in the operated group was 64.4% and 81.4%, respectively. The univariate analysis showed that factors including elevated levels of CRP and LDH, AFP 〉 10 000μg/L, embryonal histology, PRETEXT 1V and presence of metastases could significantly reduce the 5-year survival rate.Cox multivariate analysis showed that the 5-year survival rate of patients in different subgroups of histology, PRETEXT staging and the AFP level were significantly different (P 〈 0.05). Conclusion The histology, PRETEXT staging and the AFP level are independent factors influencing the prognosis of hepatoblastoma (HB)patients.Early diagnosis and active treatment based on the grasping of the clinical and laboratory characters of the disease can improve the prognosis of the patients.
出处 《中国实用儿科杂志》 CSCD 北大核心 2013年第2期126-128,共3页 Chinese Journal of Practical Pediatrics
关键词 肝母细胞瘤 预后 COX回归分析 hepatoblastoma prognosis cox regression analysis
  • 相关文献

参考文献12

  • 1曹莉萍,吕娇凤,牟秀萍,姚全良,冯伟.血清GGT、ALP和LDH联检测定对癌症患者的诊断及意义[J].实验与检验医学,2008,26(4):437-438. 被引量:18
  • 2谢勇,龙光辉,刘晓平,周晓初,钟立明.肝母细胞瘤的综合治疗及影响预后的因素评价[J].实用儿科临床杂志,2008,23(11):833-834. 被引量:8
  • 3Macintyre SS.Biosynthesis of C-reactiue protein[].Annals of the New York Academy of Sciences.2000
  • 4Brown J,Perilongo G,Shafford E,et al.Pretreatment prognostic factors for children with hepatoblastoma--results from the In ternational Society of Paediatric Oncology(SIOP)study SIO PEL1[].European Journal of Cancer.2000
  • 5De Ioris M,Brugieres L,Zimmermann A,et al.Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis:the SIO PEL group experience[].European Journal of Cancer.2008
  • 6Zsiros J,Maibach R,Schafford E,et al.Successful treatmentof childhood high-risk hepatoblastoma with dose-intensivemultiagent chemotherapy and and surgery:Final result of theSIOPEL-3HR study[].Journal of Clinical Oncology.2010
  • 7Malogolowkin MH,Katzenstein HM,Meyers RL,et al.Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology:A report from the Children’’s Oncology Group[].Journal of Clinical Oncology.2011
  • 8Ismail H,Broniszczak D,Kaliciński P,et al.Changing treatment and outcome of children with hepatoblastoma:analysis of a sin gle center experience over the last20years[].Journal of Pediatric Surgery.2012
  • 9Herzog C E,Andrassy R J,Eftekhari F.Childhood cancers: hepatoblastoma[].The Oncologist.2000
  • 10Meyers RL,Rowland JR,Krailo M,et al.Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the children’’s oncology group[].Pediatric Blood and Cancer.2009

二级参考文献19

共引文献24

同被引文献28

  • 1赵素华.小儿手术的配合护理特点[J].医学信息(医学与计算机应用),2014,0(11):260-260. 被引量:3
  • 2李颐,胡小红,王淑芳.小儿介入诊疗的围手术期护理[J].实用临床医学(江西),2005,6(6):119-120. 被引量:2
  • 3韩希文,胡志向,葛秀娟.外科手术麻醉诱导期家长陪伴对学龄前小儿心理应激反应的影响[J].中国实用儿科杂志,2006,21(7):556-556. 被引量:9
  • 4胡亚美 江载芳.诸福棠实用儿科学7版[M].北京:人民卫生出版社,2002.441.
  • 5Meyers RL, Czauderna P, Otte JB. Surgical treatment of hepato- blastoma. Pediatr Blood Cancer,2012,59(5):800-808.
  • 6Ismail H,Broniszczak D,Kalicihski P,et al.Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.J Pediatr Surg, 2012,47(7 ) : 1331-1339.
  • 7Gupta K,Rane S,Das A,et al. Relationship of beta-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma. J Pediatr Hematol Oncol,2012,34(8):320-328.
  • 8Zsiros J,Brugieres L,Brock P,et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high risk hepato- blastoma (SIOPEL4):a prospective,single-arm,feasibility study. Lancet Oncol,2013,14(9) :834-842.
  • 9Tsay PK,Lai PK,Yang CP,et al.Treatment outcomes for hepato- blastoma:Experience of 35 cases al a single institution.J Formos Med Assoc., 2011,110(5 ) :322-325.
  • 10Arora RS.Outcomes of hepatoblastoma in the Indian context.In- dian Pediatrics,2012,49(4) :307-309.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部